Jacqueline H Boudreau1, Donald R Miller2, Shirley Qian1, Eduardo R Nunez3, Tanner J Caverly4, Renda Soylemez Wiener5. 1. Center for Healthcare Organization and Implementation Research, VA Bedford Healthcare System, Bedford MA; VA Boston Healthcare System, Boston, MA. 2. Center for Healthcare Organization and Implementation Research, VA Bedford Healthcare System, Bedford MA; VA Boston Healthcare System, Boston, MA; Center for Population Health, Department of Biomedical and Nutritional Sciences, University of Massachusetts, Lowell, MA. 3. Center for Healthcare Organization and Implementation Research, VA Bedford Healthcare System, Bedford MA; VA Boston Healthcare System, Boston, MA; The Pulmonary Center, Department of Medicine, Boston University School of Medicine, Boston, MA. 4. Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, MI; Department of Learning Health Sciences and Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI. 5. Center for Healthcare Organization and Implementation Research, VA Bedford Healthcare System, Bedford MA; VA Boston Healthcare System, Boston, MA; The Pulmonary Center, Department of Medicine, Boston University School of Medicine, Boston, MA. Electronic address: rwiener@bu.edu.
Abstract
BACKGROUND: Studies show uneven access to Medicare-approved lung cancer screening (LCS) programs across the United States. The Veterans Health Administration (VA), the largest national US integrated health system, is potentially well positioned to coordinate LCS services across regional units to ensure that access matches distribution of need nationally. RESEARCH QUESTION: To what extent does LCS access (considering both VA and partner sites) and use match the distribution of eligible Veterans at state and regional levels? METHODS: In this retrospective analysis, we identified LCS examinations in VA facilities between 2013 and 2019 from the VA Corporate Data Warehouse and plotted VA facilities with LCS geographically. We compared estimated LCS rates (unique Veterans screened per LCS-eligible population) across states and VA regional units. Finally, we assessed whether the VA's new partnership with the GO2 Foundation for Lung Cancer (which includes more than 750 LCS centers) closes geographic gaps in LCS access. RESULTS: We identified 71,898 LCS examinations in 96 of 139 (69.1%) VA facilities in 44 states between 2013 and 2019, with substantial variation across states (0-8 VA LCS facilities per state). Screening rates among eligible Veterans in the population varied more than 30-fold across regional networks (rate ratio, 33.6; 95% CI, 30.8-36.7 for VA New England vs Veterans Integrated Service Network 4), with weak correlation between eligible populations and LCS rates (coefficient, -0.30). Partnering with the GO2 Foundation for Lung Cancer expands capacity and access (eg, all states now have ≥ 1 VA or partner LCS site), but 9 of the 12 states with the highest proportions of rural Veterans still have ≤ 3 total LCS facilities. INTERPRETATION: Disparities in LCS access exist based on where Veterans live, particularly for rural Veterans, even after partnering with the GO2 Foundation for Lung Cancer. The nationally integrated VA system has an opportunity to leverage regional resources to distribute and coordinate LCS services better to ensure equitable access. Published by Elsevier Inc.
BACKGROUND: Studies show uneven access to Medicare-approved lung cancer screening (LCS) programs across the United States. The Veterans Health Administration (VA), the largest national US integrated health system, is potentially well positioned to coordinate LCS services across regional units to ensure that access matches distribution of need nationally. RESEARCH QUESTION: To what extent does LCS access (considering both VA and partner sites) and use match the distribution of eligible Veterans at state and regional levels? METHODS: In this retrospective analysis, we identified LCS examinations in VA facilities between 2013 and 2019 from the VA Corporate Data Warehouse and plotted VA facilities with LCS geographically. We compared estimated LCS rates (unique Veterans screened per LCS-eligible population) across states and VA regional units. Finally, we assessed whether the VA's new partnership with the GO2 Foundation for Lung Cancer (which includes more than 750 LCS centers) closes geographic gaps in LCS access. RESULTS: We identified 71,898 LCS examinations in 96 of 139 (69.1%) VA facilities in 44 states between 2013 and 2019, with substantial variation across states (0-8 VA LCS facilities per state). Screening rates among eligible Veterans in the population varied more than 30-fold across regional networks (rate ratio, 33.6; 95% CI, 30.8-36.7 for VA New England vs Veterans Integrated Service Network 4), with weak correlation between eligible populations and LCS rates (coefficient, -0.30). Partnering with the GO2 Foundation for Lung Cancer expands capacity and access (eg, all states now have ≥ 1 VA or partner LCS site), but 9 of the 12 states with the highest proportions of rural Veterans still have ≤ 3 total LCS facilities. INTERPRETATION: Disparities in LCS access exist based on where Veterans live, particularly for rural Veterans, even after partnering with the GO2 Foundation for Lung Cancer. The nationally integrated VA system has an opportunity to leverage regional resources to distribute and coordinate LCS services better to ensure equitable access. Published by Elsevier Inc.
Authors: Liora Sahar; Vanhvilai L Douangchai Wills; Ka Kit Liu; Ella A Kazerooni; Debra S Dyer; Robert A Smith Journal: Chest Date: 2020-09-01 Impact factor: 9.410
Authors: Linda S Kinsinger; Charles Anderson; Jane Kim; Martha Larson; Stephanie H Chan; Heather A King; Kathryn L Rice; Christopher G Slatore; Nichole T Tanner; Kathleen Pittman; Robert J Monte; Rebecca B McNeil; Janet M Grubber; Michael J Kelley; Dawn Provenzale; Santanu K Datta; Nina S Sperber; Lottie K Barnes; David H Abbott; Kellie J Sims; Richard L Whitley; R Ryanne Wu; George L Jackson Journal: JAMA Intern Med Date: 2017-03-01 Impact factor: 21.873
Authors: Renda Soylemez Wiener; Michael K Gould; Douglas A Arenberg; David H Au; Kathleen Fennig; Carla R Lamb; Peter J Mazzone; David E Midthun; Maryann Napoli; David E Ost; Charles A Powell; M Patricia Rivera; Christopher G Slatore; Nichole T Tanner; Anil Vachani; Juan P Wisnivesky; Sue H Yoon Journal: Am J Respir Crit Care Med Date: 2015-10-01 Impact factor: 21.405
Authors: Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks Journal: N Engl J Med Date: 2011-06-29 Impact factor: 91.245
Authors: Peter Mazzone; Charles A Powell; Douglas Arenberg; Peter Bach; Frank Detterbeck; Michael K Gould; Michael T Jaklitsch; James Jett; David Naidich; Anil Vachani; Renda Soylemez Wiener; Gerard Silvestri Journal: Chest Date: 2015-02 Impact factor: 9.410
Authors: Jonathan Shelver; Chris H Wendt; Melissa McClure; Brian Bell; Angela E Fabbrini; Thomas Rector; Kathryn Rice Journal: J Am Coll Radiol Date: 2017-04-21 Impact factor: 5.532
Authors: Lucy B Spalluto; Jennifer A Lewis; Lauren R Samuels; Carol Callaway-Lane; Michael E Matheny; Jason Denton; Jennifer A Robles; Robert S Dittus; David F Yankelevitz; Claudia I Henschke; Pierre P Massion; Drew Moghanaki; Christianne L Roumie Journal: J Am Coll Radiol Date: 2022-01 Impact factor: 5.532
Authors: Eduardo R Núñez; Tanner J Caverly; Sanqian Zhang; Mark E Glickman; Shirley X Qian; Jacqueline H Boudreau; Donald R Miller; Renda Soylemez Wiener Journal: Chest Date: 2022-02-26 Impact factor: 10.262
Authors: Dejana Braithwaite; Shama D Karanth; Christopher G Slatore; Dongyu Zhang; Jiang Bian; Rafael Meza; Jihyoun Jeon; Martin Tammemagi; Mattthew Schabath; Meghann Wheeler; Yi Guo; Bruno Hochhegger; Frederic J Kaye; Gerard A Silvestri; Michael K Gould Journal: BMJ Open Date: 2022-06-22 Impact factor: 3.006
Authors: Raymond U Osarogiagbon; Wei Liao; Nicholas R Faris; Meghan Meadows-Taylor; Carrie Fehnel; Jordan Lane; Sara C Williams; Anita A Patel; Olawale A Akinbobola; Alicia Pacheco; Amanda Epperson; Joy Luttrell; Denise McCoy; Laura McHugh; Raymond Signore; Anna M Bishop; Keith Tonkin; Robert Optican; Jeffrey Wright; Todd Robbins; Meredith A Ray; Matthew P Smeltzer Journal: J Clin Oncol Date: 2022-03-08 Impact factor: 50.717
Authors: Eduardo R Núñez; Tanner J Caverly; Sanqian Zhang; Mark E Glickman; Shirley X Qian; Jacqueline H Boudreau; Christopher G Slatore; Donald R Miller; Renda Soylemez Wiener Journal: JAMA Netw Open Date: 2021-07-01